Berkner, SilviaSchwirn, KathrinVölker, Doris2024-06-162024-06-162022https://doi.org/10.60810/openumwelt-620https://openumwelt.de/handle/123456789/2891Advanced materials, and nanomaterials, are promising for healthcare applications and are in particular in the spotlight of medical innovation since rapidly developed nano-formulated vaccines provide relief in the SARS-CoV-2 pandemic. Further increased rapid growth is to be expected as more and more products are in development and reach the market, beneficial for human health. However, the human body is not a dead end and these products are likely to enter the environment, whereas their fate and effects in the environment are unknown. This part of the life-cycle of advanced medicinal products tends to be overlooked, if the perspective is human-centered and excludes the connectedness of human activity with, and consequences for our environment. Gaps are reviewed that exist in awareness, perspective taking, inclusion of environmental concerns into research and product development and also in available methodologies and regulatory guidance. To bridge these gaps, possible ways forward start to emerge, that could help to find a more integrative way of assessing human and environmental safety for advanced material medicinal products and nanomedicines. © The Author(s) 2022.1 Onlineresource (9 Seiten)online resourceenghttp://rightsstatements.org/vocab/InC/1.0/NanomaterialienPandemieProduktlebenszyklusREACH-SystemWissenschaftlicher Artikel